KPMG says that if proposed takeover of listed honey company fails then there is uncertainty as to how it will meet its debt obligations.
The company’s future dividend policy, which has been suspended since 2023, is based on cash generation.
Kiwi utilities-focused SaaS company says potential tariffs won't hurt its chances in the United States.
Listed transport heavyweight boosts revenue and profit while noting highly uncertain outlook.
The ASX-listed bioscience company posted a strong second half and its guidance for 2026 is bullish.
Hiving off a minority stake in Highbrook Business Park seen as a more attractive option than an equity issue.
Trade software-as-a-service business reported annual loss of $3.5m in FY25.
The cervical cancer screening device company's board warned in November it might not survive without raising more cash.
The company completed a $1b capital raise earlier this year to pay down debt.
NZX-listed waste management company landed a $40m contract earlier this month.